⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL293298 | 0.95 | — | — | |
| SCHEMBL28680101 | 0.91 | — | — | |
| SCHEMBL8916955 | 0.91 | — | — | |
| SCHEMBL8673580 | 0.91 | — | — | |
| SCHEMBL2288105 | 0.91 | — | — | |
| SCHEMBL29657106 | 0.91 | — | — | |
| Ammonia Solution, Strong SCHEMBL11211491 | 0.91 | — | — | |
| SCHEMBL18577710 | 0.91 | — | — | |
| SCHEMBL317361 | 0.91 | — | — | |
| SCHEMBL28118349 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119950687-A | Method for inhibiting diabetic retinopathy progression | 武汉科技大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119950687-A | Method for inhibiting diabetic retinopathy progression | 武汉科技大学 | 2025-05-09 | — | — | CN | disclosed |
| US-4985595-A | Anti-peptic Ulcer Agents | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-15 | — | — | US | disclosed |
| EP-0185368-B1 | AMINOBENZAMIDE DERIVATIVES | DAIICHI SEIYAKU CO., LTD. (JP) | 1990-06-06 | — | — | EP | disclosed |
| EP-0185368-A2 | Aminobenzamide derivatives | DAIICHI SEIYAKU CO., LTD. (JP) | 1986-06-25 | — | — | EP | disclosed |